Regulation of monoamine transporters: Role of transporter phosphorylation

Pharmacology and Therapeutics

Volumn 129, Issue 2, 2011, Pages 220-238

  Ramamoorthy, Sammanda ^a   Shippenberg, Toni S ^b   Jayanthi, Lankupalle D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biogenic amines; Mental illness; Phosphorylation; Regulation; Transporters

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE RECEPTOR; AMPHETAMINE; ANISOMYCIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; COCAINE; DESIPRAMINE; DOPAMINE TRANSPORTER; FENFLURAMINE; FLUOXETINE; HISTAMINE H3 RECEPTOR; IMIPRAMINE; INSULIN RECEPTOR; INTERLEUKIN 1BETA; MAZINDOL; METHAMPHETAMINE; METHYLPHENIDATE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOAMINE; MUSCARINIC RECEPTOR; NORADRENALIN TRANSPORTER; PAROXETINE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE KINASE; SEROTONIN 1B RECEPTOR; SEROTONIN TRANSPORTER; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; VANOXERINE;

AMINE TRANSPORT; ARTICLE; AUTISM; BRAIN DISEASE; BRAIN FUNCTION; COCAINE DEPENDENCE; GENETIC CODE; GENETIC VARIABILITY; HUMAN; LIPID RAFT; NEUROTRANSMISSION; NONHUMAN; ORTHOSTATIC INTOLERANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79151476913     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2010.09.009     Document Type: Review

References (272)

1. E.M. Adkins, D.J. Samuvel, J.U. Fog, J. Eriksen, L.D. Jayanthi, and C.B. Vaegter Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching Biochemistry 46 2007 10484 10497
2. W. Adriani, F. Boyer, L. Gioiosa, S. Macri, J.L. Dreyer, and G. Laviola Increased impulsive behavior and risk proneness following lentivirus-mediated dopamine transporter over-expression in rats' nucleus accumbens Neuroscience 159 2009 47 58
3. T.H. Ahern, M.A. Javors, D.A. Eagles, J. Martillotti, H.A. Mitchell, and L.C. Liles The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice Neuropsychopharmacology 31 2006 730 738
4. F. Amenta, E. Bronzetti, F. Cantalamessa, D. El-Assouad, L. Felici, and A. Ricci Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes J Neuroimmunol 117 2001 133 142
5. G.M. Anderson, and W.C. Horne Activators of protein kinase C decrease serotonin transport in human platelets Biochim Biophys Acta 1137 1992 331 337
6. Annamalai, B., Mannangatti, P., Arapulisamy, O., Ramamoorthy, S., & Jayanthi, L. D. (2010). Involvement of Threonine 258 and Serine 259 Motif in Amphetamine-Induced Norepinephrine Transporter Endocytosis. J Neurochem, "Accepted Article"; doi:10.1111/j.1471-4159.2010.06898.x
7. T.A. Ansah, S. Ramamoorthy, S. Montanez, L.C. Daws, and R.D. Blakely Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4, 5-dihydro-1H-imidazol-2-yl]-6- quinoxalinamine (UK14304) J Pharmacol Exp Ther 305 2003 956 965
8. S. Apparsundaram, A. Galli, L.J. DeFelice, H.C. Hartzell, and R.D. Blakely Acute regulation of norepinephrine transport: I. PKC-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells J Pharmacol Exp Ther 287 1998 733 743
9. S. Apparsundaram, A. Galli, L.J. DeFelice, H.C. Hartzell, and R.D. Blakely Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells J Pharmacol Exp Ther 287 1998 733 743
10. S. Apparsundaram, S. Schroeter, and R.D. Blakely Acute regulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins J Pharmacol Exp Ther 287 1998 744 751
11. S. Apparsundaram, U. Sung, R.D. Price, and R.D. Blakely Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells J Pharmacol Exp Ther 299 2001 666 677
12. D.F. Balkovetz, C. Tiruppathi, F.H. Leibach, V.B. Mahesh, and V. Ganapathy Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes J Biol Chem 264 1989 2195 2198
13. M.J. Bannon, J.G. Granneman, and G.K. The dopamine transporter. Potential involvement in neuropsychiatric disorders F.E. Bloom, K.D. Psychopharmacology: the Fourth Generation of Progress 1995 Raven Press New York 179 187
14. E.L. Barker, and R.D. Blakely Norepinephrine and serotonin transporters: Molecular targets of antidepressant drugs F.E. Bloom, D.J. Kupfer, Psychopharmacology: The Fourth Generation of Progress 1995 Raven Press New York 321 333
15. A.L. Bauman, S. Apparsundaram, S. Ramamoorthy, B.E. Wadzinski, R.A. Vaughan, and R.D. Blakely Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A J Neurosci 20 2000 7571 7578
16. D. Bengel, D.L. Murphy, A.M. Andrews, C.H. Wichems, D. Feltner, and A. Heils Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymetamphetamine ("ecstasy") in serotonin transporter-deficient mice Mol Pharmacol 53 1998 649 655
17. S. Benmansour, T. Deltheil, J. Piotrowski, L. Nicolas, C. Reperant, and A.M. Gardier Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents Eur J Pharmacol 587 2008 90 98
18. F. Binda, C. Dipace, E. Bowton, S.D. Robertson, B.J. Lute, and J.U. Fog Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux Mol Pharmacol 74 2008 1101 1108
19. F. Binda, B.J. Lute, C. Dipace, R.D. Blakely, and A. Galli The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current Neuropharmacology 50 2006 354 361
20. R.D. Blakely, H.E. Berson, R.T. Fremeau Jr., M.G. Caron, M.M. Peek, and H.K. Prince Cloning and expression of a functional serotonin transporter from rat brain Nature 354 1991 66 70
21. P. Blier Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles J Psychiatry Neurosci 26 2001 S1 S2 (Suppl)
22. M. Bohm, K. La Rosse, R.H.G. Schwinger, and E. Erdmann Evidence for reduction norepinephrine uptake sites in the failing human heart J Am Coll Cardiol 25 1995 146 153
23. L.M. Bohn, F. Xu, R.R. Gainetdinov, and M.G. Caron Potentiated opioid analgesia in norepinephrine transporter knock-out mice J Neurosci 20 2000 9040 9045
24. E.A. Bolan, B. Kivell, V. Jaligam, M. Oz, L.D. Jayanthi, and Y. Han D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism Mol Pharmacol 71 2007 1222 1232
25. H. Bonisch, and M. Bruss The norepinephrine transporter in physiology and disease Handb Exp Pharmacol 2006 485 524
26. H. Bönisch, R. Hammermann, and M. Brüss Role of protein kinase C and second messengers in regulation of the norepinephrine transporter Adv Pharmacol 42 1998 183 187
27. E. Boudanova, D.M. Navaroli, Z. Stevens, and H.E. Melikian Dopamine transporter endocytic determinants: Carboxy terminal residues critical for basal and PKC-stimulated internalization Mol Cell Neurosci 39 2008 211 217
28. E. Bowton, C. Saunders, K. Erreger, D. Sakrikar, H.J. Matthies, and N. Sen Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder J Neurosci 30 2010 6048 6057
29. F.T. Boyd, D.W. Clarke, T.F. Muther, and M.K. Raizada Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain J Biol Chem 260 1985 15880 15884
30. F.T. Boyd, D.W. Clarke, and M.K. Raizada Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain Brain Res 398 1986 1 5
31. M. Brüss, J. Kunz, B. Lingen, and H. Bönisch Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter Hum Genet 91 1993 278 280
32. A. Carlsson Perspectives on the discovery of central monoaminergic neurotransmission Annu Rev Neurosci 10 1987 19 40
33. A.M. Carneiro, D.C. Airey, B. Thompson, C.B. Zhu, L. Lu, and E.J. Chesler Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes Proc Natl Acad Sci USA 106 2009 2047 2052
34. A.M. Carneiro, and R.D. Blakely Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter J Biol Chem 281 2006 24769 24780
35. A.M. Carneiro, E.H. Cook, D.L. Murphy, and R.D. Blakely Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans J Clin Invest 118 2008 1544 1552
36. M.G. Caron, and R.R. Gainetdinov Role of dopamine transporters in neuronal homeostasis L.L. Iversen, S.D. Iversen, S.B. Dunnett, A. BjÖrklund, Dopamine Handbook 2010 Oxford New York 88 99
37. L. Carvelli, R.D. Blakely, and L.J. DeFelice Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission Proc Natl Acad Sci USA 105 2008 14192 14197
38. L. Carvelli, J.A. Moron, K.M. Kahlig, J.V. Ferrer, N. Sen, and J.D. Lechleiter PI 3-kinase regulation of dopamine uptake J Neurochem 81 2002 859 869
39. M.A. Cervinski, J.D. Foster, and R.A. Vaughan Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms J Biol Chem 280 2005 40442 40449
40. L.H. Chamberlain, and G.W. Gould The vesicle- and target-SNARE proteins that mediate Glut4 vesicle fusion are localized in detergent-insoluble lipid rafts present on distinct intracellular membranes J Biol Chem 277 2002 49750 49754
41. A.S. Chang, D.M. Starnes, and S.M. Chang Possible existence of quaternary structure in the high-affinity serotonin transport complex Biochem Biophys Res Commun 249 1998 416 421
42. M.Y. Chang, S.H. Lee, J.H. Kim, K.H. Lee, Y.S. Kim, and H. Son Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein J Neurochem 77 2001 754 761
43. F. Chaouloff, O. Berton, and P. Mormede Serotonin and stress Neuropsychopharmacology 21 1999 28S 32S
44. N. Chen, M. Appell, J.L. Berfield, and M.E. Reith Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter Eur J Pharmacol 478 2003 89 95
45. R. Chen, C.A. Furman, M. Zhang, M.N. Kim, R.W.t. Gereau, and M. Leitges Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice J Pharmacol Exp Ther 328 2009 912 920
46. J.G. Chen, S. Liu-Chen, and G. Rudnick Determination of external loop topology in the serotonin transporter by site-directed chemical labeling J Biol Chem 273 1998 12675 12681
47. L. Chi, and M.E. Reith Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations J Pharmacol Exp Ther 307 2003 729 736
48. P. Cirillo, P. Golino, M. Ragni, C. Battaglia, F. Pacifico, and S. Formisano Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors Cardiovasc Res 43 1999 210 218
49. E.F. Coccaro Central serotonin and impulsive aggression Br J Psychiatry 155 1989 52 62
50. P. Compagnon, D. Ernouf, G. Narcisse, and M. Daoust Serotonin in animal models of alcoholism Alcohol Suppl 2 1993 215 219
51. B.J. Copeland, V. Vogelsberg, N.H. Neff, and M. Hadjiconstantinou Protein kinase C activators decrease dopamine uptake into striatal synaptosomes J Pharmacol Exp Ther 277 1996 1527 1532
52. G.M. Daniels, and S.G. Amara Regulated trafficking of the human dopamine transporter. Clathrin- mediated internalization and lysosomal degradation in response to phorbol esters J Biol Chem 274 1999 35794 35801
53. L.C. Daws, P.D. Callaghan, J.A. Moron, K.M. Kahlig, T.S. Shippenberg, and J.A. Javitch Cocaine increases dopamine uptake and cell surface expression of dopamine transporters Biochem Biophys Res Commun 290 2002 1545 1550
54. L.C. Daws, G.A. Gerhardt, and A. Frazer 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus Neurosci Lett 266 1999 165 168
55. L.C. Daws, G.G. Gould, S.D. Teicher, G.A. Gerhardt, and A. Frazer 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo J Neurochem 75 2000 2113 2122
56. S.D. Dickinson, J. Sabeti, G.A. Larson, K. Giardina, M. Rubinstein, and M.A. Kelly Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum J Neurochem 72 1999 148 156
57. C. Dipace, U. Sung, F. Binda, R.D. Blakely, and A. Galli Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes Mol Pharmacol 71 2007 230 239
58. S. Doolen, and N.R. Zahniser Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes J Pharmacol Exp Ther 296 2001 931 938
59. S. Doolen, and N.R. Zahniser Conventional protein kinase C isoforms regulate human dopamine transporter activity in Xenopus oocytes FEBS Lett 516 2002 187 190
60. B. Eisensamer, M. Uhr, S. Meyr, G. Gimpl, T. Deiml, and G. Rammes Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains J Neurosci 25 2005 10198 10206
61. J. Eriksen, T.N. Jorgensen, and U. Gether Regulation of dopamine transporter function by protein-protein interactions: New discoveries and methodological challenges J Neurochem 113 2010 27 41
62. J. Eriksen, S.G. Rasmussen, T.N. Rasmussen, C.B. Vaegter, J.H. Cha, and M.F. Zou Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs J Neurosci 29 2009 6794 6808
63. M. Esler, M. Alvarenga, C. Pier, J. Richards, A. El-Osta, and D. Barton The neuronal noradrenaline transporter, anxiety and cardiovascular disease J Psychopharmacol 20 2006 60 66
64. M. Esler, G. Jackman, A. Bobik, P. Leonard, D. Kelleher, and H. Skews Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients Hypertension 3 1981 149 156
65. B.A. Faraj, Z.L. Olkowski, and R.T. Jackson Expression of a high-affinity serotonin transporter in human lymphocytes Int J Immunopharmacol 16 1994 561 567
66. V. Fauchey, M. Jaber, M.G. Caron, B. Bloch, and C. Le Moine Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter Eur J Neurosci 12 2000 19 26
67. D.P. Figlewicz, K. Bentson, and I. Ocrant The effect of insulin on norepinephrine uptake by PC12 cells Brain Res Bull 32 1993 425 431
68. D.P. Figlewicz, P. Szot, P.A. Israel, C. Payne, and D.M. Dorsa Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus Brain Res 602 1993 161 164
69. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu Rev Pharmacol Toxicol 47 2007 681 698
70. J.U. Fog, H. Khoshbouei, M. Holy, W.A. Owens, C.B. Vaegter, and N. Sen Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport Neuron 51 2006 417 429
71. A.C. Fontana, M.S. Sonders, O.S. Pereira-Junior, M. Knight, J.A. Javitch, and V. Rodrigues Two allelic isoforms of the serotonin transporter from Schistosoma mansoni display electrogenic transport and high selectivity for serotonin Eur J Pharmacol 616 2009 48 57
72. S.L. Foote, F.E. Bloom, and G. Aston-Jones Nucleus locus ceruleus: New evidence of anatomical and physiological specificity Physiol Rev 63 1983 844 914
73. J.D. Foster, S.D. Adkins, J.R. Lever, and R.A. Vaughan Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol J Neurochem 105 2008 1683 1699
74. J.D. Foster, M.A. Cervinski, B.K. Gorentla, and R.A. Vaughan Regulation of the dopamine transporter by phosphorylation Handb Exp Pharmacol 2006 197 214
75. J.D. Foster, B. Pananusorn, M.A. Cervinski, H.E. Holden, and R.A. Vaughan Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1 Brain Res Mol Brain Res 110 2003 100 108
76. J.D. Foster, B. Pananusorn, and R.A. Vaughan Dopamine transporters are phosphorylated on N-terminal serines in rat striatum J Biol Chem 277 2002 25178 25186
77. F. Fumagalli, R.R. Gainetdinov, K.J. Valenzano, and M.G. Caron Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter J Neurosci 18 1998 4861 4869
78. R.R. Gainetdinov, and M.G. Caron Monoamine transporters: From genes to behavior Annu Rev Pharmacol Toxicol 43 2003 261 284
79. R.R. Gainetdinov, S.R. Jones, and M.G. Caron Functional hyperdopaminergia in dopamine transporter knock-out mice Biol Psychiatry 46 1999 303 311
80. R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, E.D. Levin, M. Jaber, and M.G. Caron Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 1999 397 401
81. B.G. Garcia, Y. Wei, J.A. Moron, R.Z. Lin, J.A. Javitch, and A. Galli Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution Mol Pharmacol 68 2005 102 109
82. J. Gelernter, S. Kruger, A.J. Pakstis, T. Pacholczyk, R.S. Sparkes, and K.K. Kidd Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16 Genomics 18 1993 690 692
83. V. Ghisi, A.J. Ramsey, B. Masri, R.R. Gainetdinov, M.G. Caron, and A. Salahpour Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter Cell Signal 21 2009 87 94
84. B. Giros, S. El Mestikawy, N. Godinot, K. Zheng, H. Han, and T. Yang-Feng Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Mol Pharmacol 42 1992 383 390
85. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
86. R.A. Glennon, and M. Dukat Serotonin receptor subtypes F.E. Bloom, D.J. Kupfer, Psychopharmacology: The Fourth Generation of Progress 1995 Raven Press, Ltd. New York 415 429
87. M. Gobbi, T. Mennini, and S. Garratini Mechanism of neurotransmitter release induced by amphetamine derivatives: pharmacological and toxicological aspects Curr Top Pharmacol 3 1997 217 227
88. J.S. Goodwin, G.A. Larson, J. Swant, N. Sen, J.A. Javitch, and N.R. Zahniser Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo J Biol Chem 284 2009 2978 2989
89. J. Gordon, and N.M. Barnes Lymphocytes transport serotonin and dopamine: Agony or ecstasy? Trends Immunol 24 2003 438 443
90. B.K. Gorentla, A.E. Moritz, J.D. Foster, and R.A. Vaughan Proline-directed phosphorylation of the dopamine transporter N-terminal domain Biochemistry 48 2009 1067 1076
91. B.K. Gorentla, and R.A. Vaughan Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation Neuropharmacology 49 2005 759 768
92. C. Granas, J. Ferrer, C.J. Loland, J.A. Javitch, and U. Gether N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization J Biol Chem 278 2003 4990 5000
93. J.M. Gulley, and N.R. Zahniser Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands Eur J Pharmacol 479 2003 139 152
94. B. Guptaroy, M. Zhang, E. Bowton, F. Binda, L. Shi, and H. Weinstein A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation Mol Pharmacol 75 2009 514 524
95. B. Haenisch, K. Linsel, M. Bruss, R. Gilsbach, P. Propping, and M.M. Nothen Association of major depression with rare functional variants in norepinephrine transporter and serotonin(1A) receptor genes Am J Med Genet B Neuropsychiatr Genet 150B 2008 1013 1016
96. M.K. Hahn, J.U. Blackford, K. Haman, M. Mazei-Robison, B.A. English, and H.C. Prasad Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression Genes Brain Behav 7 2008 487 495
97. M.K. Hahn, and R.D. Blakely The functional impact of SLC6 transporter genetic variation Annu Rev Pharmacol Toxicol 47 2007 401 441
98. M.K. Hahn, M.S. Mazei-Robison, and R.D. Blakely Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation Mol Pharmacol 68 2005 457 466
99. M.K. Hahn, D. Robertson, and R.D. Blakely A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters J Neurosci 23 2003 4470 4478
100. F.S. Hall, X.F. Li, I. Sora, F. Xu, M. Caron, and K.P. Lesch Cocaine mechanisms: Enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions Neuroscience 115 2002 153 161
101. J. Haller, N. Bakos, R.M. Rodriguiz, M.G. Caron, W.C. Wetsel, and Z. Liposits Behavioral responses to social stress in noradrenaline transporter knockout mice: Effects on social behavior and depression Brain Res Bull 58 2002 279 284
102. D.M. Helmeste, and S.W. Tang Tyrosine kinase inhibitors regulate serotonin uptake in platelets Eur J Pharmacol 280 1995 R5 R7
103. B. Hilber, P. Scholze, M.M. Dorostkar, W. Sandtner, M. Holy, and S. Boehm Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines Neuropharmacology 49 2005 811 819
104. B.J. Hoffman, E. Mezey, and M.J. Brownstein Cloning of a serotonin transporter affected by antidepressants Science 254 1991 579 580
105. K.L. Holton, M.K. Loder, and H.E. Melikian Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization Nat Neurosci 8 2005 881 888
106. B.R. Hoover, C.V. Everett, A. Sorkin, and N.R. Zahniser Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations J Neurochem 101 2007 1258 1271
107. max J Neurochem 68 1997 225 232
108. M. Imamura, H.M. Lander, and R. Levi Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors Circ Res 78 1996 475 481
109. L.L. Iversen Role of transmitter uptake mechanisms in synaptic neurotransmission Br J Pharmacol 41 1971 571 591
110. L.L. Iversen Uptake processes for biogenic amines I. Iversen, Handbook of Psychopharmacology 3 ed. 1978 Prenum Press New York 381 442
111. L.D. Jayanthi, B. Annamalai, D.J. Samuvel, U. Gether, and S. Ramamoorthy Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization J Biol Chem 281 2006 23326 23340
112. Jayanthi, L. D., Mannangatti, P., Arapulisamy, O., & Ramamoorthy, S. (2010). Cocaine upregulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase. Paper presented at the Society for Neuroscience.
113. L.D. Jayanthi, and S. Ramamoorthy Regulation of monoamine transporters: Influence of psychostimulants and therapeutic antidepressants AAPS J 7 2005 E728 E738
114. L.D. Jayanthi, S. Ramamoorthy, V.B. Mahesh, F.H. Leibach, and V. Ganapathy Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells J Biol Chem 269 1994 14424 14429
115. L.D. Jayanthi, D.J. Samuvel, R.D. Blakely, and S. Ramamoorthy Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation Mol Pharmacol 67 2005 2077 2087
116. L.D. Jayanthi, D.J. Samuvel, and S. Ramamoorthy Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization J Biol Chem 279 2004 19315 19326
117. L.D. Jayanthi, G. Vargas, and L.J. DeFelice Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts Br J Pharmacol 135 2002 1927 1934
118. U. Jess, H. Betz, and P. Schloss The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein Fed Exp Biol Sci 394 1996 44 46
119. L.A. Johnson, C.A. Furman, M. Zhang, B. Guptaroy, and M.E. Gnegy Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation Neuropharmacology 49 2005 750 758
120. L.A. Johnson, B. Guptaroy, D. Lund, S. Shamban, and M.E. Gnegy Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta J Biol Chem 280 2005 10914 10919
121. S.R. Jones, R.R. Gainetdinov, X.T. Hu, D.C. Cooper, R.M. Wightman, and F.J. White Loss of autoreceptor functions in mice lacking the dopamine transporter Nat Neurosci 2 1999 649 655
122. S.R. Jones, R.R. Gainetdinov, M. Jaber, B. Giros, R.M. Wightman, and M.G. Caron Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc Natl Acad Sci USA 95 7 1998 4029
123. J.B. Justice Jr., K.S. Danek, J.W. Kable, E.L. Barker, and R.D. Blakely Voltammetric approaches to kinetics and mechanism of the norepinephrine transporter Adv Pharmacol 42 1998 191 194
124. N.R. Keller, A. Diedrich, M. Appalsamy, L.C. Miller, M.G. Caron, and M.P. McDonald Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension Neuroscience 139 2006 931 946
125. N.R. Keller, A. Diedrich, M. Appalsamy, S. Tuntrakool, S. Lonce, and C. Finney Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity Circulation 110 2004 1191 1196
126. H. Khoshbouei, N. Sen, B. Guptaroy, L. Johnson, D. Lund, and M.E. Gnegy N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux PLoS Biol 2 2004 16
127. F. Kilic, D.L. Murphy, and G. Rudnick A human serotonin transporter mutation causes constitutive activation of transport activity Mol Pharmacol 64 2003 440 446
128. F. Kilic, and G. Rudnick Oligomerization of serotonin transporter and its functional consequences Proc Natl Acad Sci USA 97 2000 3106 3111
129. J.E. Kilty, D. Lorang, and S.G. Amara Cloning and expression of a cocaine-sensitive rat dopamine transporter Science 254 1991 578 580
130. C.H. Kim, M.K. Hahn, Y. Joung, S.L. Anderson, A.H. Steele, and M.S. Mazei-Robinson A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder Proc Natl Acad Sci USA 103 2006 19164 19169
131. S. Kitayama, K. Morita, and T. Dohi Functional characterization of the splicing variants of human norepinephrine transporter Neurosci Lett 312 2001 108 112
132. V. Klimek, C. Stockmeier, J. Overholser, H.Y. Meltzer, S. Kalka, and G. Dilley Reduced levels of norepinephrine transporters in the locus coeruleus in major depression J Neurosci 17 1997 8451 8458
133. G.F. Koob Drug abuse and alcoholism. Overview Adv Pharmacol 42 1998 969 977
134. G.F. Koob, P.P. Sanna, and F.E. Bloom Neuroscience of addiction Neuron 21 1998 467 476
135. J. Launay, D. Bondoux, M. Oset-Gasque, S. Emami, V. Mutel, and M. Haimart Increase of human platelet serotonin uptake by atypical histamine receptors Am J Physiol 266 1994 526 536
136. F.J. Lee, L. Pei, A. Moszczynska, B. Vukusic, P.J. Fletcher, and F. Liu Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor EMBO J 26 2007 2127 2136
137. B.E. Leonard The role of noradrenaline in depression: A review J Psychopharmacol 11 1997 S39 S47
138. K.P. Lesch, B.L. Wolozin, H.C. Estler, D.L. Murphy, and P. Riederer Isolation of a cDNA encoding the human brain serotonin transporter J Neural Transm 91 1993 67 72
139. K.P. Lesch, B.L. Wolozin, D.L. Murphy, and P. Riederer Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter J Neurochem 60 1993 2319 2322
140. Q. Li, L. Ma, R.B. Innis, N. Seneca, M. Ichise, and H. Huang Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5- fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)] benzonitrile (DASB) J Pharmacol Exp Ther 308 2004 481 486
141. Q. Li, C. Wichems, A. Heils, L.D. Van De Kar, K.P. Lesch, and D.L. Murphy Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice J Pharmacol Exp Ther 291 1999 999 1007
142. C. Liang, T.-H.M. Fan, J.T. Sullebarger, and S. Sakamoto Decreased adrenergic neuronal uptake activity in experimental right heart failure J Clin Invest 84 1989 1267 1275
143. Z. Lin, and G.R. Uhl Human dopamine transporter gene variation: Effects of protein coding variants V55A and V382A on expression and uptake activities Pharmacogenomics J 3 2003 159 168
144. Z. Lin, P.W. Zhang, X. Zhu, J.M. Melgari, R. Huff, and R.L. Spieldoch PI3, PKC and MEK1/2 kinase regulation of dopamine transporters (DAT) requires N-terminal DAT phosphoacceptor sites J Biol Chem 26 2003 26
145. K.Y. Little, L.W. Elmer, H. Zhong, J.O. Scheys, and L. Zhang Cocaine induction of dopamine transporter trafficking to the plasma membrane Mol Pharmacol 61 2002 436 445
146. J. Logan, G.J. Wang, F. Telang, J.S. Fowler, D. Alexoff, and J. Zabroski Imaging the norepinephrine transporter in humans with (S, S)-[11C]O-methyl reboxetine and PET: problems and progress Nucl Med Biol 34 2007 667 679
147. D. Lu, K. Yu, M.R. Paddy, N.E. Rowland, and M.K. Raizada Regulation of norepinephrine transport system by angiotensin II in neuronal cultures of normotensive and spontaneously hypertensive rat brains Endocrinology 137 1996 763 772
148. B.J. Lute, H. Khoshbouei, C. Saunders, N. Sen, R.Z. Lin, and J.A. Javitch PI3K signaling supports amphetamine-induced dopamine efflux Biochem Biophys Res Commun 372 2008 656 661
149. B.K. Madras, G.M. Miller, and A.J. Fischman The dopamine transporter and attention-deficit/hyperactivity disorder Biol Psychiatry 57 2005 1397 1409
150. F. Magnani, C.G. Tate, S. Wynne, C. Williams, and J. Haase Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin J Biol Chem 279 2004 38770 38778
151. P. Mandela, and G.A. Ordway The norepinephrine transporter and its regulation J Neurochem 97 2006 310 333
152. D.C. Mash, J. Pablo, Q. Ouyang, W.L. Hearn, and S. Izenwasser Dopamine transport function is elevated in cocaine users J Neurochem 81 2002 292 300
153. N. Matheus, C. Mendoza, R. Iceta, J.E. Mesonero, and A.I. Alcalde Regulation of serotonin transporter activity by adenosine in intestinal epithelial cells Biochem Pharmacol 78 2009 1198 1204
154. H.J. Matthies, Q. Han, A. Shields, J. Wright, J.L. Moore, and D.G. Winder Subcellular localization of the antidepressant-sensitive norepinephrine transporter BMC Neurosci 10 2009 65
155. H.J. Matthies, J.L. Moore, C. Saunders, D.S. Matthies, L.A. Lapierre, and J.R. Goldenring Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking J Neurosci 30 2010 7863 7877
156. R.D. Mayfield, and N.R. Zahniser Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent Mol Pharmacol 59 2001 113 121
157. M.S. Mazei-Robison, and R.D. Blakely Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala Neuropharmacology 49 2005 737 749
158. M.S. Mazei-Robinson, and R.D. Blakely ADHD and the dopamine transporter: Are there reasons to pay attention? Handb Exp Pharmacol 2006 373 415
159. M.S. Mazei-Robison, E. Bowton, M. Holy, M. Schmudermaier, M. Freissmuth, and H.H. Sitte Anomalous dopamine release associated with a human dopamine transporter coding variant J Neurosci 28 2008 7040 7046
160. K. McFarland, and P.W. Kalivas The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior J Neurosci 21 2001 8655 8663
161. S.M. Meiergerd, T.A. Patterson, and J.O. Schenk D2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo J Neurochem 61 1993 764 767
162. H.E. Melikian Neurotransmitter transporter trafficking: Endocytosis, recycling, and regulation Pharmacol Ther 104 2004 17 27
163. H.E. Melikian, and K.M. Buckley Membrane trafficking regulates the
164. H.Y. Meltzer, R.C. Arora, R. Baber, and B.J. Tricou Serotonin uptake in blood platelets of psychiatric patients Arch Gen Psychiatry 38 1981 1322 1326
165. P. Merlet, J.-L. Dubois-Rande, S. Adnot, M.H. Bourguignon, C. Benvenuti, and D. Loisance Myocardial β-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy J Cardiovasc Pharmacol 19 1992 10 16
166. 3 receptors regulate serotonin transoprt via nitric oxide and cGMP J Biol Chem 269 44 1994 27351 27356
167. L.H. Miner, H.P. Jedema, F.W. Moore, R.D. Blakely, A.A. Grace, and S.R. Sesack Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex J Neurosci 26 2006 1571 1578
168. M. Miranda, K.R. Dionne, T. Sorkina, and A. Sorkin Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter Mol Biol Cell 18 2007 313 323
169. M. Miranda, C.C. Wu, T. Sorkina, D.R. Korstjens, and A. Sorkin Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C J Biol Chem 280 2005 35617 35624
170. H.A. Mitchell, T.H. Ahern, L.C. Liles, M.A. Javors, and D. Weinshenker The effects of norepinephrine transporter inactivation on locomotor activity in mice Biol Psychiatry 60 2006 1046 1052
171. R.Y. Moore, and F.E. Bloom Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems Annu Rev Neurosci 2 1979 113 168
172. J.A. Moron, A. Brockington, R.A. Wise, B.A. Rocha, and B.T. Hope Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines J Neurosci 22 2002 389 395
173. J.A. Moron, I. Zakharova, J.V. Ferrer, G.A. Merrill, B. Hope, and E.M. Lafer Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity J Neurosci 23 2003 8480 8488
174. O.V. Mortensen, M.B. Larsen, B.M. Prasad, and S.G. Amara Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking Mol Biol Cell 19 2008 2818 2829
175. D.L. Murphy, A. Lerner, G. Rudnick, and K.P. Lesch Serotonin transporter: Gene, genetic disorders, and pharmacogenetics Mol Interv 4 2004 109 123
176. D.L. Musselman, U. Marzec, M. Davidoff, A.K. Manatunga, F. Gao, and A. Reemsnyder Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment Depress Anxiety 15 2002 91 101
177. E.J. Nestler, and W.A. Carlezon Jr. The mesolimbic dopamine reward circuit in depression Biol Psychiatry 59 2006 1151 1159
178. M.J. Owens, and C.B. Nemeroff Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter Clin Chem 40 1994 288 295
179. M. Oz, V. Jaligam, S. Galadari, G. Petroianu, Y.M. Shuba, and T.S. Shippenberg The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism J Neurochem 114 2009 1019 1929
180. M. Oz, T. Libby, B. Kivell, V. Jaligam, S. Ramamoorthy, and T.S. Shippenberg Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+ J Neurochem 114 2010 1019 1029
181. N. Ozaki, D. Goldman, W.H. Kaye, K. Plotnicov, B.D. Greenberg, and J. Lappalainen Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype Mol Psychiatry 8 2003 933 936
182. T. Pacholczyk, R.D. Blakely, and S.G. Amara Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter Nature 350 1991 350 354
183. N.J. Paczkowski, H.E. Vuocolo, and L.J. Bryan-Lluka Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat Naunyn Schmiedebergs Arch Pharmacol 353 1996 423 430
184. G. Page, M. Peeters, M. Najimi, J.M. Maloteaux, and E. Hermans Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes J Neurochem 76 2001 1282 1290
185. R.G. Parton, and A.A. Richards Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms Traffic 4 2003 724 738
186. H.C. Prasad, J.A. Steiner, J.S. Sutcliffe, and R.D. Blakely Enhanced activity of human serotonin transporter variants associated with autism Philos Trans R Soc Lond B Biol Sci 364 2009 163 173
187. H.C. Prasad, C.B. Zhu, J.L. McCauley, D.J. Samuvel, S. Ramamoorthy, and R.C. Shelton Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase Proc Natl Acad Sci USA 102 2005 11545 11550
188. D.A. Price, W.A. Owens, G.G. Gould, A. Frazer, J.L. Roberts, and L.C. Daws CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum J Neurochem 101 2007 389 396
189. D.A. Price, A. Sorkin, and N.R. Zahniser Cyclin-dependent kinase 5 inhibitors: Inhibition of dopamine transporter activity Mol Pharmacol 76 2009 812 823
190. Z.B. Pristupa, F. McConkey, F. Liu, H.Y. Man, F.J. Lee, and Y.T. Wang Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter Synapse 30 1998 79 87
191. Y. Qian, A. Galli, S. Ramamoorthy, S. Risso, L.J. DeFelice, and R.D. Blakely Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression J Neurosci 17 1997 45 57
192. R.J. Ralph, M.P. Paulus, F. Fumagalli, M.G. Caron, and M.A. Geyer Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: Differential effects of D1 and D2 receptor antagonists J Neurosci 21 2001 305 313
193. S. Ramamoorthy Regulation of monoamine transporters: Regulated phosphorylation, dephhosphorylation, and trafficking 2nd ed. 2002 Humana Press Inc. Totowa, NJ Vol. Book Chapter 1
194. S. Ramamoorthy, A.L. Bauman, K.R. Moore, H. Han, T. Yang-Feng, and A.S. Chang Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization Proc Natl Acad Sci USA 90 1993 2542 2546
195. S. Ramamoorthy, and R.D. Blakely Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants Science 285 1999 763 766
196. S. Ramamoorthy, E. Giovanetti, Y. Qian, and R.D. Blakely Phosphorylation and regulation of antidepressant-sensitive serotonin transporters J Biol Chem 273 1998 2458 2466
197. S. Ramamoorthy, F.H. Leibach, V.B. Mahesh, and V. Ganapathy Partial purification and characterization of the human placental serotonin transporter Placenta 14 1993 449 461
198. S. Ramamoorthy, D.J. Samuvel, A. Balasubramaniam, R.E. See, and L.D. Jayanthi Altered dopamine transporter function and phosphorylation following chronic cocaine self-administration and extinction in rats Biochem Biophys Res Commun 391 2010 1517 1521
199. S. Ramamoorthy, D.J. Samuvel, E.R. Buck, G. Rudnick, and L.D. Jayanthi Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP J Biol Chem 282 2007 11639 11647
200. T.N. Rasmussen, P. Plenge, T. Bay, J. Egebjerg, and U. Gether A single nucleotide polymorphism in the human serotonin transporter introduces a new site for N-linked glycosylation Neuropharmacology 57 2009 287 294
201. M.E.A. Reith, C. Xu, and N.H. Chen Pharmacology and regulation of the neuronal dopamine transporter Eur J Pharmacol 324 1997 1 10
202. K.J. Ressler, and C.B. Nemeroff Role of norepinephrine in the pathophysiology and treatment of mood disorders Biol Psychiatry 46 1999 1219 1233
203. T.L. Richards, and N.R. Zahniser Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens J Neurochem 108 2009 1575 1584
204. A. Rioux, V. Fabre, K.P. Lesch, R. Moessner, D.L. Murphy, and L. Lanfumey Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter Neurosci Lett 262 1999 113 116
205. M.C. Ritz, R.J. Lamb, S.R. Goldberg, and M.J. Kuhar Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science 237 1987 1219 1223
206. S.D. Robertson, H.J. Matthies, and A. Galli A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters Mol Neurobiol 39 2009 73 80
207. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res Brain Res Rev 18 1993 247 291
208. B.A. Rocha, F. Fumagalli, R.R. Gainetdinov, S.R. Jones, R. Ator, and B. Giros Cocaine self-administration in dopamine-transporter knockout mice Nat Neurosci 1 1998 132 137
209. G. Rudnick Active transport of 5-hydroxytryptamine by plasma membrane vesicles isolated from human blood platelets J Biol Chem 252 1977 2170 2174
210. G. Rudnick, and S.C. Wall The molecular mechanism of "ecstasy" [3, 4-methylenedioxymethamphetamine (MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release Proc Natl Acad Sci USA 89 1992 1817 1821
211. M.S. Rumantir, D.M. Kaye, G.L. Jennings, M. Vaz, J.A. Hastings, and M.D. Esler Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension Hypertension 36 2000 824 829
212. D.J. Samuvel, L.D. Jayanthi, N.R. Bhat, and S. Ramamoorthy A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: Evidence for distinct cellular mechanisms involved in transporter surface expression J Neurosci 25 2005 29 41
213. D.J. Samuvel, L.D. Jayanthi, S. Manohar, K. Kaliyaperumal, R.E. See, and S. Ramamoorthy Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: Evidence for differential regulation in caudate putamen and nucleus accumbens J Pharmacol Exp Ther 325 2008 293 301
214. C. Saunders, J.V. Ferrer, L. Shi, J. Chen, G. Merrill, and M.E. Lamb Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism Proc Natl Acad Sci USA 97 2000 6850 6855
215. V. Savchenko, U. Sung, and R.D. Blakely Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody Mol Cell Neurosci 24 2003 1131 1150
216. S.M. Scanlon, D.C. Williams, and P. Schloss Membrane cholesterol modulates serotonin transporter activity Biochemistry 40 2001 10507 10513
217. M. Schafers, D. Dutka, C.G. Rhodes, A.A. Lammertsma, F. Hermansen, and O. Schober Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy Circ Res 82 1998 57 62
218. J.J. Schildkraut The catecholamine hypothesis of affective disorders: A review of supporting evidence Am J Psychiatry 122 1965 509 522
219. J.A. Schmid, H. Just, and H.H. Sitte Impact of oligomerization on the function of the human serotonin transporter Biochem Soc Trans 29 2001 732 736
220. J.A. Schmid, P. Scholze, O. Kudlacek, M. Freissmuth, E.A. Singer, and H.H. Sitte Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells J Biol Chem 276 2001 3805 3810
221. S. Schroeter, S. Apparsundaram, R.G. Wiley, L.H. Miner, S.R. Sesack, and R.D. Blakely Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter J Comp Neurol 420 2000 211 232
222. S. Schroeter, A.I. Levey, and R.D. Blakely Polarized expression of the antidepressant-sensitive serotonin transporter in epinephrine-synthesizing chromaffin cells of the rat adrenal gland Mol Cell Neurosci 9 1997 170 184
223. S. Seidel, E.A. Singer, H. Just, H. Farhan, P. Scholze, and O. Kudlacek Amphetamines take two to tango: An oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action Mol Pharmacol 67 2005 140 151
224. E.M. Sellers, G.A. Higgins, D.M. Tompkins, and M.K. Romach Serotonin and alcohol drinking NIDA Res Monogr 119 1992 141 145
225. J.R. Shannon, N.L. Flattem, J. Jordan, G. Jacob, B.K. Black, and I. Biaggioni Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency N Engl J Med 342 2000 541 549
226. S. Shimada, S. Kitayama, C. Lin, A. Patel, E. Nanthakumar, and P. Gregor Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA Science 254 1991 576 577
227. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
228. K. Simons, and D. Toomre Lipid rafts and signal transduction Nat Rev Mol Cell Biol 1 2000 31 39
229. M.A. Siuta, S.D. Robertson, H. Kocalis, C. Saunders, P.J. Gresch, and V. Khatri Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice PLoS Biol 8 2010 e1000393
230. M. Solinas, Z. Justinova, S.R. Goldberg, and G. Tanda Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats J Neurochem 98 2006 408 419
231. I. Sora, F.S. Hall, A.M. Andrews, M. Itokawa, X.F. Li, and H.B. Wei Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference Proc Natl Acad Sci USA 98 2001 5300 5305
232. I. Sora, C. Wichems, N. Takahashi, X.F. Li, Z. Zeng, and R. Revay Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice Proc Natl Acad Sci USA 95 1998 7699 7704
233. T. Sorkina, B.R. Hoover, N.R. Zahniser, and A. Sorkin Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism Traffic 6 2005 157 170
234. J.A. Steiner, A.M. Carneiro, and R.D. Blakely Going with the flow: Trafficking-dependent and -independent regulation of serotonin transport Traffic 9 2008 1393 1402
235. J.A. Steiner, A.M. Carneiro, J. Wright, H.J. Matthies, H.C. Prasad, and C.K. Nicki cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake Mol Brain 2 2009 26
236. S. Sucic, S. Dallinger, B. Zdrazil, R. Weissensteiner, T.N. Jorgensen, and M. Holy The N terminus of monoamine transporters is a lever required for the action of amphetamines J Biol Chem 285 2010 10924 10938
237. C. Sumners, and M.K. Raizada Angiotensin II stimulates norepinephrine uptake in hypothalamus-brain stem neuronal cultures Am J Physiol 250 1986 C236 C244
238. U. Sung, S. Apparsundaram, A. Galli, K.M. Kahlig, V. Savchenko, and S. Schroeter A regulated interaction of syntaxin 1A with the antidepressant- sensitive norepinephrine transporter establishes catecholamine clearance capacity J Neurosci 23 2003 1697 1709
239. J.S. Sutcliffe, R.J. Delahanty, H.C. Prasad, J.L. McCauley, Q. Han, and L. Jiang Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors Am J Hum Genet 77 2005 265 279
240. A.C. Thompson, A. Zapata, J.B. Justice, R.A. Vaughan, L.G. Sharpe, and T.S. Shippenberg Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine J Neurosci 20 2000 9333 9340
241. G.E. Torres, and S.G. Amara Glutamate and monoamine transporters: New visions of form and function Curr Opin Neurobiol 17 2007 304 312
242. G.E. Torres, R.R. Gainetdinov, and M.G. Caron Plasma membrane monoamine transporters: Structure, regulation and function Nat Rev Neurosci 4 2003 13 25
243. U. Trendelenburg The TiPs lecture: Functional aspects of the neuronal uptake of noradrenaline Trends Pharmacol Sci 32 1991 334 337
244. 3H]noradrenaline uptake in PC12 cells J Neurosci 1997 1 27
245. J. Uchida, Y. Kiuchi, M. Ohno, A. Yura, and K. Oguchi Ca(2+)-dependent enhancement of [3H]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases Brain Res 809 1998 155 164
246. R.A. Vaughan Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters J Pharmacol Exp Ther 310 2004 1 7
247. R.A. Vaughan, R.A. Huff, G.R. Uhl, and M.J. Kuhar Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes J Biol Chem 272 1997 15541 15546
248. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, and D. Franceschi Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am J Psychiatry 158 2001 377 382
249. N.S. Vrindavanam, P. Arnaud, J.X. Ma, S. Altman-Hamamdzic, N.P. Parratto, and F.R. Sallee The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter Neurosci Lett 216 1996 133 136
250. Y. Wei, J.M. Williams, C. Dipace, U. Sung, J.A. Javitch, and A. Galli Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism Mol Pharmacol 71 2007 835 842
251. D. Weintraub, A.B. Newberg, M.S. Cary, A.D. Siderowf, P.J. Moberg, and G. Kleiner-Fisman Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease J Nucl Med 46 2005 227 232
252. T.L. Whitworth, L.C. Herndon, and M.W. Quick Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons J Neurosci 22 2002 RC192
253. J.M. Williams, W.A. Owens, G.H. Turner, C. Saunders, C. Dipace, and R.D. Blakely Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine PLoS Biol 5 2007 e274
254. J.M. Williams, W.A. Owens, G.H. Turner, C. Saunders, C. Dipace, and R.D. Blakely Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine PLoS Biol 5 2007 2369 2378
255. A. Wirz-Justice Platelet research in psychiatry Experientia 44 1988 145 152
256. F. Xu, R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, L.M. Bohn, and G.W. Miller Mice lacking the norepinephrine transporter are supersensitive to psychostimulants Nat Neurosci 3 2000 465 471
257. - dependent neurotransmitter transporters Nature 437 2005 215 223
258. 1 receptors J Neurosci 17 1997 1660 1669
259. H. Yang, and M.K. Raizada Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat J Neurosci 19 1999 2413 2423
260. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems Pharmacol Ther 92 2001 21 55
261. N.R. Zahniser, and A. Sorkin Rapid regulation of the dopamine transporter: Role in stimulant addiction? Neuropharmacology 47 Suppl 1 2004 80 91
262. A. Zapata, B. Kivell, Y. Han, J.A. Javitch, E.A. Bolan, and D. Kuraguntla Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors J Biol Chem 282 2007 35842 35854
263. A. Zarpellon, A. Donella-Deana, A. Folda, L. Turetta, M. Pavanetto, and R. Deana Serotonin (5-HT) transport in human platelets is modulated by Src-catalysed Tyr-phosphorylation of the plasma membrane transporter SERT Cell Physiol Biochem 21 2008 87 94
264. Y.W. Zhang, J. Gesmonde, S. Ramamoorthy, and G. Rudnick Serotonin transporter phosphorylation by cGMP-dependent protein kinase is altered by a mutation associated with obsessive compulsive disorder J Neurosci 27 2007 10878 10886
265. M.-Y. Zhu, R.D. Blakely, S. Apparsundaram, and G.A. Ordway Downregulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine J Neurochem 70 1998 1547 1555
266. C.B. Zhu, R.D. Blakely, and W.A. Hewlett The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters Neuropsychopharmacology 31 2006 2121 2131
267. C.B. Zhu, A.M. Carneiro, W.R. Dostmann, W.A. Hewlett, and R.D. Blakely p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process J Biol Chem 280 2005 15649 15658
268. C.B. Zhu, W.A. Hewlett, I. Feoktistov, I. Biaggioni, and R.D. Blakely Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation Mol Pharmacol 65 2004 1462 1474
269. C.B. Zhu, W.A. Hewlett, S.H. Francis, J.D. Corbin, and R.D. Blakely Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil Eur J Pharmacol 504 2004 1 6
270. S.J. Zhu, M.P. Kavanaugh, M.S. Sonders, S.G. Amara, and N.R. Zahniser Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes J Pharmacol Exp Ther 282 1997 1358 1365
271. M.Y. Zhu, S. Shamburger, J. Li, and G.A. Ordway Regulation of the human norepinephrine transporter by cocaine and amphetamine J Pharmacol Exp Ther 295 2000 951 959
272. C.B. Zhu, J.A. Steiner, J.L. Munn, L.C. Daws, W.A. Hewlett, and R.D. Blakely Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors J Pharmacol Exp Ther 322 2007 332 340